Novo Nordisk, the pharmaceutical powerhouse behind the blockbuster Ozempic, has been riding a wave of success. Ozempic, a treatment for type 2 diabetes that has also gained widespread attention for its weight loss benefits, has helped fuel Novo Nordisk’s recent stock performance. But what’s in store for Novo Nordisk’s stock price over the next few years? Whether you're an investor or considering jumping in, let’s dive into the forecast for 2025, 2026 and 2030. Table of Contents

Current Overview of Ozempic (Novo Nordisk) Stock

Methodology for Stock Price Prediction

Ozempic Stock Price Prediction for 2025

See All 6 Items

Current Overview of Ozempic (Novo Nordisk) Stock

Novo Nordisk (NVO) has seen significant growth over the past year, with its stock price at $69.21. With a market ca

See Full Page